This review summarizes current knowledge on the pathophysiology, therapeutic strategies, and prognosis of peripartum cardiomyopathy.
Updates clinicians on peripartum cardiomyopathy management; leaves open need for prospective trials to refine therapy.
Peripartum cardiomyopathy is a form of dilated cardiomyopathy of indeterminate aetiology occurring in late pregnancy or the months following delivery. This article reviews current knowledge of its pathophysiology, therapeutic strategies and prognosis, as well as new treatments and future directions.
No takes yet. Share an insight, caveat, or question.
Grixti et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: